HKD 0.23
(-1.74%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 537.22 Million HKD | -25.34% |
2022 | 719.52 Million HKD | -12.32% |
2021 | 820.66 Million HKD | 0.2% |
2020 | 819.05 Million HKD | 13.6% |
2019 | 720.97 Million HKD | -36.55% |
2018 | 1.13 Billion HKD | -6.7% |
2017 | 1.21 Billion HKD | -5.06% |
2016 | 1.28 Billion HKD | -7.39% |
2015 | 1.38 Billion HKD | -4.83% |
2014 | 1.45 Billion HKD | -14.94% |
2013 | 1.71 Billion HKD | -21.1% |
2012 | 2.16 Billion HKD | 74.4% |
2011 | 1.24 Billion HKD | 1142.61% |
2010 | 100.08 Million HKD | -31.2% |
2009 | 145.47 Million HKD | -19.07% |
2008 | 179.76 Million HKD | -48.71% |
2007 | 350.5 Million HKD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 558.88 Million HKD | 0.0% |
2024 Q1 | 558.88 Million HKD | 4.03% |
2023 Q1 | 602.23 Million HKD | -16.3% |
2023 Q2 | 602.23 Million HKD | 0.0% |
2023 FY | 537.22 Million HKD | -25.34% |
2023 Q3 | 556.87 Million HKD | -7.53% |
2023 Q4 | 537.22 Million HKD | -3.53% |
2022 FY | 719.52 Million HKD | -12.32% |
2022 Q3 | 640.44 Million HKD | -29.46% |
2022 Q2 | 907.85 Million HKD | 8.81% |
2022 Q1 | 834.38 Million HKD | 1.67% |
2022 Q4 | 719.52 Million HKD | 12.35% |
2021 FY | 820.66 Million HKD | 0.2% |
2021 Q2 | 795.72 Million HKD | 0.0% |
2021 Q4 | 820.66 Million HKD | 10.05% |
2021 Q1 | 795.72 Million HKD | -2.85% |
2021 Q3 | 745.73 Million HKD | -6.28% |
2020 Q3 | 819.05 Million HKD | -41.35% |
2020 FY | 819.05 Million HKD | 13.6% |
2020 Q4 | 819.05 Million HKD | 0.0% |
2020 Q1 | 1.39 Billion HKD | 93.69% |
2020 Q2 | 1.39 Billion HKD | 0.0% |
2019 FY | 720.97 Million HKD | -36.55% |
2019 Q2 | 963.33 Million HKD | 0.0% |
2019 Q3 | 720.97 Million HKD | -25.16% |
2019 Q4 | 720.97 Million HKD | 0.0% |
2019 Q1 | 963.33 Million HKD | -15.23% |
2018 Q3 | 1.13 Billion HKD | -5.38% |
2018 FY | 1.13 Billion HKD | -6.7% |
2018 Q2 | 1.2 Billion HKD | 0.0% |
2018 Q4 | 1.13 Billion HKD | 0.0% |
2018 Q1 | 1.2 Billion HKD | -1.4% |
2017 Q4 | 1.21 Billion HKD | 0.0% |
2017 FY | 1.21 Billion HKD | -5.06% |
2017 Q3 | 1.21 Billion HKD | -2.07% |
2017 Q2 | 1.24 Billion HKD | 0.0% |
2017 Q1 | 1.24 Billion HKD | -3.06% |
2016 Q2 | 1.22 Billion HKD | 0.0% |
2016 Q3 | 1.28 Billion HKD | 4.95% |
2016 Q1 | 1.22 Billion HKD | -11.75% |
2016 FY | 1.28 Billion HKD | -7.39% |
2016 Q4 | 1.28 Billion HKD | 0.0% |
2015 Q1 | 1 Billion HKD | -30.74% |
2015 FY | 1.38 Billion HKD | -4.83% |
2015 Q4 | 1.38 Billion HKD | 0.0% |
2015 Q3 | 1.38 Billion HKD | 23.49% |
2015 Q2 | 1.12 Billion HKD | 11.28% |
2014 FY | 1.45 Billion HKD | -14.94% |
2014 Q4 | 1.45 Billion HKD | 0.0% |
2014 Q3 | 1.45 Billion HKD | -4.8% |
2014 Q2 | 1.52 Billion HKD | 0.0% |
2014 Q1 | 1.52 Billion HKD | -10.65% |
2013 Q4 | 1.71 Billion HKD | 0.0% |
2013 FY | 1.71 Billion HKD | -21.1% |
2013 Q1 | 1.96 Billion HKD | -9.59% |
2013 Q2 | 1.96 Billion HKD | 0.0% |
2013 Q3 | 1.71 Billion HKD | -12.73% |
2012 Q3 | 2.16 Billion HKD | 70.09% |
2012 Q2 | 1.27 Billion HKD | 0.0% |
2012 FY | 2.16 Billion HKD | 74.4% |
2012 Q4 | 2.16 Billion HKD | 0.0% |
2011 FY | 1.24 Billion HKD | 1142.61% |
2011 Q2 | 875.23 Million HKD | 0.0% |
2011 Q4 | 1.24 Billion HKD | 0.0% |
2010 Q4 | 100.08 Million HKD | 0.0% |
2010 FY | 100.08 Million HKD | -31.2% |
2010 Q2 | 157.21 Million HKD | 0.0% |
2009 Q2 | 126.02 Million HKD | 0.0% |
2009 FY | 145.47 Million HKD | -19.07% |
2009 Q4 | 145.47 Million HKD | 0.0% |
2008 Q4 | 179.76 Million HKD | 0.0% |
2008 FY | 179.76 Million HKD | -48.71% |
2007 FY | 350.5 Million HKD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Starlite Holdings Limited | 266.35 Million HKD | -101.694% |
Touyun Biotech Group Limited | 586.26 Million HKD | 8.366% |
Champion Alliance International Holdings Limited | 99.22 Million HKD | -441.399% |
Huaxi Holdings Company Limited | 173.29 Million HKD | -210.0% |